https://skl2001agonist.com/flu....orometer-for-screeni
Prostate cancer diagnosis often relies on PSA testing; however, its inaccuracy renders it an imperfect method of assessment. Despite the availability of various urine- or tissue-based gene expression assays for characterizing patients predisposed to adverse diseases and for assisting in treatment decisions, the need for reliable biomarkers that monitor disease progression and response to therapy remains substantial.
처럼
논평
공유하다
